Prevalence and predictors of complementary and alternative medicine use in African-Americans with acquired immune deficiency syndrome.
Prevalence and predictors of complementary and alternative medicine use in African-Americans with acquired immune deficiency syndrome.
复制标题
DOI：
10.1111/j.2042-7166.2011.01140.x
复制
发表时间：
2012-03-01
期刊：
影响因子：
--
通讯作者：
Diclemente, Ralph
中科院分区：
文献类型：
--
作者：
Owen-Smith, Ashli;McCarty, Frances;Diclemente, Ralph
背景：在人类免疫缺陷病毒(HIV)阳性个体中使用补充和替代医学(CAM)正变得越来越普遍。不幸的是，一些CAM疗法可能会危及传统HIV药物的疗效，因此了解CAM在这一人群中的使用至关重要。目的：从理论驱动、多维度的角度探讨CAM使用的流行率和预测因素。方法：招募被诊断为获得性免疫缺陷综合征(AIDS)的非裔美国人。这项由计算机管理的调查询问了参与者使用CAM的情况，以及各种心理社会和社会人口特征。参与者最近的CD4+细胞计数和HIV RNA水平是从医疗记录中提取的。对潜在的混杂因素进行了调整后的线性回归分析，以评估各种因素在解释CAM使用频率方面的独立贡献。结果：182名受试者参与了调查。结果表明，大多数(94%)参与者使用了至少一种类型的CAM治疗。大多数参与者(79.7%)使用CAM疗法作为他们艾滋病毒药物的补充(而不是替代疗法)，尽管一半的人没有与他们的医疗保健提供者讨论这些疗法。女性、高年收入、高健康素养和高HIV RNA水平与使用CAM的频率较高相关，而较强的情绪幸福感与较低的使用频率相关。结论：讨论了这些发现的意义，并对未来的研究提出了建议。
BACKGROUND: The use of complementary and alternative medicine (CAM) among Human Immunodeficiency Virus (HIV)-positive individuals is becoming increasingly widespread. Unfortunately, some CAM therapies may jeopardize the efficacy of conventional HIV medication, making it critical to understand CAM use among this population. OBJECTIVE: To investigate the prevalence and predictors of CAM use in a theory-driven, multidimensional manner. METHODS: African-American individuals who had received a diagnosis of acquired immune deficiency syndrome (AIDS) were recruited. The computer-administered survey asked questions about participants' CAM use and various psychosocial and socio-demographic characteristics. Participants' most recent CD4+ cell counts and HIV RNA levels were abstracted from medical records. Linear regression analyses, adjusted for potential confounders, were conducted to assess the independent contribution of various factors in explaining frequency of CAM use. RESULTS: One hundred and eighty two subjects participated in the survey. Results indicate that most (94%) participants used at least one type of CAM therapy. The majority of participants (79.7%) used CAM therapies as a complement (rather than an alternative) to their HIV medications though half had not discussed these therapies with their healthcare providers. Female sex, high yearly income, high health literacy and high HIV RNA levels were associated with a greater frequency of CAM use, while stronger emotional well-being was associated with a lower frequency of CAM use. CONCLUSIONS: The implications of these findings are discussed and suggestions for future research are provided.